Otsuka Holdings Co. Ltd
Research Otsuka Holdings Co. Ltd (OS1) on Bullrun: market cap EUR 34.15B, P/E 15.7, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOS1
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 34.15B
- P/E15.7
- Dividend yield1.4%
- Financial periodFY2025
- RevenueJPY 2.47T
- Revenue growth6.0%
- Net incomeJPY 363.15B
- Free cash flowJPY 261.91B
- Gross margin71.7%
Valuation Snapshot
latest market cap is EUR 34.15B; P/E is 15.7; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 15.74x versus a Healthcare sector median of 24.46x (35.7% below).
Latest dividend yield is 1.44% versus a Healthcare sector median of 2.11% (31.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 2.47T | JPY 363.15B | JPY 261.91B | 71.7% | n/a | JPY 534.65B | JPY 227.98B | JPY 3.03T |
| FY2024 | JPY 2.33T | JPY 343.12B | JPY 225.28B | 71.7% | 633.76 | JPY 426.17B | JPY 189.38B | JPY 2.73T |
| FY2023 | JPY 2.02T | JPY 121.62B | JPY 168.56B | 69.7% | 224.1 | JPY 513.34B | JPY 214.19B | JPY 2.39T |
| FY2022 | JPY 1.74T | JPY 133.91B | JPY 104.06B | 67.2% | 246.78 | JPY 471.63B | JPY 194.16B | JPY 2.23T |
| FY2021 | n/a | n/a | n/a | n/a | 231.15 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 34.15B | 15.7 | 1.7% | 1.1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.1 EUR, yield 1.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.76 JPY |
| FY2024 | 0.65 JPY |
| FY2023 | 0.6 JPY |
| FY2022 | 0.54 JPY |
| FY2021 | 0.54 JPY |
About Otsuka Holdings Co. Ltd
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Otsuka Holdings Co. Ltd's market cap?
Otsuka Holdings Co. Ltd's market capitalization is EUR 34.15B.
What is Otsuka Holdings Co. Ltd's P/E ratio?
Otsuka Holdings Co. Ltd's price-to-earnings (P/E) ratio is 15.7.
Does Otsuka Holdings Co. Ltd pay a dividend?
Otsuka Holdings Co. Ltd has a dividend yield of 1.4%.
What does Otsuka Holdings Co. Ltd do?
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.